Article

Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in Sweden

2024-03-16

Abstract excerpt

Immune checkpoint inhibitors (ICIs) are linked to diverse immune-related adverse events (irAEs). Rare irAEs surface first in clinical practice. Here, we systematically studied the rare irAE, cytokine-release syndrome (CRS), in a cohort of 2672 patients treated with ICIs at Karolinska University Hospital in Stockholm, Sweden. We find that the risk of ICI-induced CRS – defined as fever, negative microbiological find...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3637121c-f41a-5a38-8123-acca0d611825
DOI: 10.1101/2024.03.15.24304338

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in SwedenDOI 10.1101/2024.03.15.24304338Read

Cytokine release syndrome in severe COVID-19Semantic proximity Read

Cytokine release syndrome and successful response to pembrolizumab therapy in a patient with EGFR-mutated non-small-cell lung cancer: A case report.Semantic proximity Read

Cytokine Release Syndrome–Compatible Fever After Initiation of Local Radiotherapy During Late-Phase Epcoritamab Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case ReportSemantic proximity Read

Advances in Prognostic Biomarkers and Targeted Immunomodulation in Severe Cutaneous Adverse ReactionsSemantic proximity Read

Construction and evaluation of clinical prediction model for immunotherapy-related adverse events and clinical benefit in cancer patients receiving immune checkpoint inhibitors based on serum cytokine levelsSemantic proximity Read

<i>In vitro</i> Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19Semantic proximity Read

Cytokine Storm SyndromeSemantic proximity Read

Marker genes for predicting cytokine release syndrome in vitro before CAR T cell infusionSemantic proximity Read

Prediction and treatment of skin adverse reactions related to inhibitors at immune checkpointsSemantic proximity Read

Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodiesSemantic proximity Read

Marker genes for predicting cytokine release syndrome in vitro before CAR T cell infusionSemantic proximity Read

Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort StudySemantic proximity Read